William Plovanic
Stock Analyst at Canaccord Genuity
(3.27)
# 920
Out of 4,670 analysts
128
Total ratings
47.37%
Success rate
2.12%
Average return
Main Sectors:
Stocks Rated by William Plovanic
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TMDX TransMedics Group | Maintains: Buy | $109 → $104 | $76.04 | +36.77% | 4 | Nov 20, 2024 | |
| TLSI TriSalus Life Sciences | Maintains: Buy | $12 → $11 | $4.53 | +142.83% | 3 | Nov 15, 2024 | |
| CBLL CeriBell | Maintains: Buy | $30 → $31 | $26.31 | +17.83% | 2 | Nov 13, 2024 | |
| NVRO Nevro | Maintains: Hold | $8 → $7 | $4.52 | +54.87% | 10 | Nov 12, 2024 | |
| TNDM Tandem Diabetes Care | Maintains: Buy | $57 → $56 | $30.81 | +81.76% | 2 | Nov 7, 2024 | |
| GMED Globus Medical | Maintains: Buy | $79 → $85 | $84.72 | +0.33% | 1 | Nov 6, 2024 | |
| BVS Bioventus | Maintains: Buy | $12 → $15 | $11.71 | +28.10% | 4 | Nov 6, 2024 | |
| CVRX CVRx, Inc. | Maintains: Buy | $15 → $17 | $14.85 | +14.48% | 5 | Oct 30, 2024 | |
| ATRC AtriCure | Maintains: Buy | $49 → $53 | $35.74 | +48.31% | 8 | Oct 30, 2024 | |
| NARI Inari Medical | Maintains: Buy | $71 → $74 | $49.66 | +49.01% | 14 | Oct 29, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $66 → $63 | $70.48 | -10.61% | 23 | Oct 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $98 | $90.00 | +8.89% | 8 | Oct 24, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $13 → $12 | $6.83 | +75.70% | 5 | Oct 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $236 → $269 | $262.93 | +2.31% | 2 | Sep 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $122 → $137 | $73.99 | +85.16% | 8 | Sep 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $120 → $115 | $110.22 | +4.34% | 2 | Sep 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $6 → $3 | $0.89 | +238.98% | 2 | Aug 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $145 → $89 | $72.83 | +22.20% | 3 | Jul 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $284 | $244.84 | +15.99% | 4 | Feb 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $22 → $25 | $10.06 | +148.51% | 1 | Jan 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $20 → $12 | $6.79 | +76.73% | 5 | Oct 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $86 → $70 | $105.33 | -33.54% | 4 | Aug 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $77 → $48 | $26.68 | +79.91% | 5 | Aug 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $21 → $22 | $10.41 | +111.34% | 3 | Jul 25, 2023 |
TransMedics Group
Nov 20, 2024
Maintains: Buy
Price Target: $109 → $104
Current: $76.04
Upside: +36.77%
TriSalus Life Sciences
Nov 15, 2024
Maintains: Buy
Price Target: $12 → $11
Current: $4.53
Upside: +142.83%
CeriBell
Nov 13, 2024
Maintains: Buy
Price Target: $30 → $31
Current: $26.31
Upside: +17.83%
Nevro
Nov 12, 2024
Maintains: Hold
Price Target: $8 → $7
Current: $4.52
Upside: +54.87%
Tandem Diabetes Care
Nov 7, 2024
Maintains: Buy
Price Target: $57 → $56
Current: $30.81
Upside: +81.76%
Globus Medical
Nov 6, 2024
Maintains: Buy
Price Target: $79 → $85
Current: $84.72
Upside: +0.33%
Bioventus
Nov 6, 2024
Maintains: Buy
Price Target: $12 → $15
Current: $11.71
Upside: +28.10%
CVRx, Inc.
Oct 30, 2024
Maintains: Buy
Price Target: $15 → $17
Current: $14.85
Upside: +14.48%
AtriCure
Oct 30, 2024
Maintains: Buy
Price Target: $49 → $53
Current: $35.74
Upside: +48.31%
Inari Medical
Oct 29, 2024
Maintains: Buy
Price Target: $71 → $74
Current: $49.66
Upside: +49.01%
Oct 25, 2024
Maintains: Hold
Price Target: $66 → $63
Current: $70.48
Upside: -10.61%
Oct 24, 2024
Maintains: Buy
Price Target: $98
Current: $90.00
Upside: +8.89%
Oct 4, 2024
Maintains: Buy
Price Target: $13 → $12
Current: $6.83
Upside: +75.70%
Sep 25, 2024
Maintains: Buy
Price Target: $236 → $269
Current: $262.93
Upside: +2.31%
Sep 25, 2024
Maintains: Buy
Price Target: $122 → $137
Current: $73.99
Upside: +85.16%
Sep 10, 2024
Maintains: Hold
Price Target: $120 → $115
Current: $110.22
Upside: +4.34%
Aug 13, 2024
Maintains: Buy
Price Target: $6 → $3
Current: $0.89
Upside: +238.98%
Jul 26, 2024
Maintains: Buy
Price Target: $145 → $89
Current: $72.83
Upside: +22.20%
Feb 23, 2024
Reiterates: Buy
Price Target: $284
Current: $244.84
Upside: +15.99%
Jan 22, 2024
Maintains: Buy
Price Target: $22 → $25
Current: $10.06
Upside: +148.51%
Oct 31, 2023
Maintains: Buy
Price Target: $20 → $12
Current: $6.79
Upside: +76.73%
Aug 28, 2023
Maintains: Hold
Price Target: $86 → $70
Current: $105.33
Upside: -33.54%
Aug 3, 2023
Downgrades: Hold
Price Target: $77 → $48
Current: $26.68
Upside: +79.91%
Jul 25, 2023
Maintains: Buy
Price Target: $21 → $22
Current: $10.41
Upside: +111.34%